Mydecine Innovations Group

Home
United States
Denver, CO
Mydecine Innovations Group

Mydecine subsidiary, Mindleap Health, as also built out a world-class mental health app for personal therapy and for clinical trial use (Mindleap.com).

Mydecine (NEO:MYCO) (OTC:MYCOF) has built out facilities in Denver and Canada that are dedicated to developing innovative solutions from fungal sources for treating mental health disorders and enhancing vitality with psychedelic and functional mushrooms. Mydecine Innovations Group™ (NEO: MYCO) (OTC:MYCOF) is a life sciences company dedicated to developing and commercializing innovative solutions f

or treating mental health problems and enhancing wellbeing. The company’s world-renowned scientists are building out a robust R&D pipeline and developing a strong IP portfolio of nature-sourced psychedelic therapeutics, novel compounds, and unique delivery systems. Mydecine has a fully certified CGMP pharmaceutical facility with the ability to research psychedelic compounds with full government approval through Health Canada. Mydecine also operates out of a state-of-the-art mycology lab in Denver, CO to focus on genetic and pharmacology research on (non-psychedelic) medicinal mushrooms.

Address

Denver, CO

Website

http://www.mydecine.com/

Alerts

Be the first to know and let us send you an email when Mydecine Innovations Group posts news and promotions. Your email address will not be used for any other purpose, and you can unsubscribe at any time.